News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Candidates’ Forum for Election of New WHO Regional Director of Africa
Photo taken from WHO African Region/X
Jul 11, 2024, 12:29

Candidates’ Forum for Election of New WHO Regional Director of Africa

WHO African Region shared on X:

“Join the live forum for candidates proposed by Member States for election as the next WHO Regional Director of Africa.

  • 22 July 2024
  • 09:30−16:00 Brazzaville time

Watch on WHO African Region social media channels and website.”

Learn more.
Source: WHO African Region/X

cancer OncoDaily Oncology Regional Director of Africa WHO African Region WHO Election
Insight
Aug 27, 2024, 03:50
Jose Debes: Right attitude to fight HPB cancers in Africa
Insight
Aug 27, 2024, 03:39
Shuchi Gulati: Sumanta K. Pal on the role of gut microbiome to optimize immunotherapy in cancer at CCCC24
Insight
Aug 27, 2024, 03:36
SIO - ASCO guidelines for treatment of common cancer symptoms
Insight
Aug 27, 2024, 03:29
David Lee: Awesome to be the host country for ESTRO meets Asia 2024
Insight
Aug 27, 2024, 03:25
Daniel Castellano: HABEMUS ESMO football 2024 tournament
Insight
Aug 27, 2024, 03:21
An open letter to policy makers: Effects of the climate crisis on cancer
Insight
Aug 27, 2024, 03:17
Understanding how cells communicate both spatially and temporally in an article by Liu et al.
Blog
Aug 27, 2024, 03:14
Sendurai Mani: How Monkeys Taught Me About Responsibility and Looking Beyond the Obvious
Insight
Aug 27, 2024, 03:11
Castalia Fernández: The molecular era of treatment of gliomas
Insight
Aug 27, 2024, 03:05
Ashish M. Kamat: Bladder-sparing Therapy for BCG–unresponsive NMIBC
Insight
Aug 27, 2024, 02:59
Anne Knisely: Metronidazole and Cefazolin for SSI prophylaxis in gynaecological surgery
Blog
Aug 26, 2024, 21:44
Tanja Obradovic: Can we expect new EGFR TKI to surpass osimertinib in primary tumor and intracranial progression of NSCLC